CDDW 2009 Abstracts TOC
Return to Main Menu
Search CDDW 2009 Abstracts
POSTER SESSION 2 - Viral Hepatitis
268 - PREVALENCE AND RISK FACTORS OF THYROID ABNORMALITIES IN PATIENTS TREATED FOR HEPATITIS C VIRUS
269 - DEBIO-025 MONOTHERAPY RESULTS IN SUSTAINED VIROLOGICAL RESPONSE IN HCV GENOTYPE 3
270 - DYNAMICS OF INTRAHOST VIRAL EVOLUTION OF A COMPLEX HEPATITIS B VIRUS VARIANT
271 - CASE SERIES FROM THE TORONTO WESTERN HOSPITAL LIVER CENTRE: WHEN HEPATITIS C IS MORE THAN A LIV...
272 - NEUROCOGNITIVE DYSFUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN NON-CIRRHOTIC CHRONIC HEPATITI...
273 - OPTIMIZING ASSESSMENT AND TREATMENT FOR HEPATITIS C VIRUS (HCV) INFECTION IN ILLICIT DRUG USERS...
274 - FACTORS ASSOCIATED WITH RESPONSE TO THERAPY DURING TREATMENT FOR ACUTE AND EARLY CHRONIC HCV IN...
275 - PRESENCE OF RTA194T AT BASELINE DOES NOT REDUCE EFFICACY TO TENOFOVIR (TDF) IN PATIENTS WITH LA...
276 - LAMIVUDINE-RESISTANT MUTATION DETECTED AMONG TREATMENT-NAÏVE HEPATITIS B PATIENTS IS COMMON AND...
277 - LIVER BIOPSIES FOR CHRONIC HEPATITIS C: SHOULD NON ULTRASOUND GUIDED BIOPSIES BE ABANDONED?
278 - RE-INFECTION FOLLOWING SUCCESSFUL TREATMENT FOR HEPATITIS C VIRUS INFECTION
279 - THE EFFECTS OF TREATMENT FOR HEPATITIS C VIRUS INFECTION IN METHADONE MAINTENANCE AND NON METHA...
280 - WHY ARE ABORIGINAL PEOPLE TREATED FOR HEPATITIS C WITH PEG-INTERFERON AND RIBAVIRIN LESS FREQUE...
281 - LOW RATE OF PERSISTENT RE-INFECTION FOLLOWING SUSTAINED VIROLOGICAL RESPONSE AMONG INJECTION DR...
282 - SAFETY AND EFFICACY OF SUBSTITUTING TENOFOVIR FOR OTHER NUCLEOSIDE ANALOGUES IN VIROLOGICALLY C...
283 - TENOFOVIR DF IN PREGNANCY: FINDINGS FROM THE ANTIRETROVIRAL PREGNANCY REGISTRY (APR)